← Thyra

Clinical AI Pilot Metrics That Matter: How to Evaluate Clinical AI Beyond the Demo

By Jean Jacques Nya Ngatchou, MD · May 28, 2026

TL;DR

A polished demo does not prove a clinical AI system will reduce after-hours work, improve inbox throughput, or survive compliance review in a real outpatient setting.

For healthcare IT administrators, the most reliable pilot scorecard covers 5 categories: workflow breadth, time impact, adoption and training burden, safety and compliance, and deployment fit.

The strongest pilots capture a baseline before launch, then measure outcomes at weeks 2, 4, and 8, especially when the tool runs as an EHR overlay on Athenahealth, Epic, or eClinicalWorks.

If a vendor cannot define how it will reduce inbox burden, documentation burden, or training burden in measurable terms, the organization is being asked to buy on faith.

This is the kind of measurement Thyra was built to welcome. Thyra is an AI-powered EHR with a Smart Inbox, Smart Search, and a longitudinal patient record that runs as a SMART on FHIR overlay on the current EHR. Because it deploys on top of Epic, Athena, or eClinicalWorks, a pilot can run against a pre-measured baseline for four to six weeks and be removed without disruption if it does not move the metrics that matter.

A strong demo can hide the issues that make clinical AI fail after purchase: inbox complexity, fragmented patient history, specialty workflow gaps, training drag, and weak auditability. Teams often leave a vendor call saying clinicians liked it, then spend the next 60 to 90 days discovering that the product solves one narrow documentation task while adding friction elsewhere.

For a healthcare IT administrator, that is not just a usability issue. It is a procurement risk, compliance risk, and rollout risk.

Why Do Clinical AI Demos Mislead Buyers?

Clinical AI demos mislead buyers because they optimize for a controlled note-generation moment, while real deployment is judged by inbox volume, retrieval speed, training overhead, and governance readiness.

Most demos show a clean encounter, a clean transcript, and a clean note. Real outpatient care does not work that way. Primary care teams handle refill requests, portal messages, prior authorizations, lab follow-up, and fragmented histories. Endocrinology teams may also need to review CGM data from Dexcom or Libre, reconcile prior notes, and connect that information to treatment decisions quickly.

What Do Demos Usually Leave Out?

The biggest omissions are operational, and those omissions explain why EHR software has not reliably reduced documentation burden. Documentation is rarely the whole job. The burden comes from the work around the note: searching for context, resolving messages, reviewing prior decisions, and cleaning up unfinished tasks after clinic hours.

Common blind spots include:

This is also why inbox management is often the main driver of clinician burnout in outpatient settings. The inbox is where refill requests, patient messages, lab follow-up, and administrative leftovers accumulate into after-hours work. If a vendor improves note generation but leaves inbox work untouched, burnout usually persists with a different interface. We covered this distinction directly in our analysis of the difference between an AI scribe, an EHR overlay, and a full workflow system.

What Metrics Should Measure Clinical AI Pilot Success?

Clinical AI pilot success should be measured with decision-grade metrics across workflow, time, adoption, compliance, and deployment, not note quality alone.

A useful scorecard should tell an IT administrator whether the platform is worth expanding, whether staff can be trained without excessive support load, and whether compliance review will slow or block rollout.

Which 5 Categories Matter Most?

Category What to measure Why it predicts success
Workflow breadthWhether the tool touches inbox, search, and follow-up, or only the noteNarrow tools leave the largest burden untouched
Time impactAfter-hours EHR minutes per clinician per day, measured before and during pilotThis is the metric burnout actually tracks
Adoption and trainingTime to competence per role and ongoing support ticketsHigh training drag predicts stalled rollout
Safety and complianceWhether every AI-assisted action is auditable and policy-alignedWeak auditability blocks or delays go-live
Deployment fitWhether the tool runs on the current EHR or requires migrationDisruptive deployment raises cost and risk

How should each category be scored?

Each category should be scored against a measured baseline, not a vendor claim. For time impact, log after-hours EHR minutes per clinician for two weeks before the pilot starts. For workflow breadth, count how many of the clinician's daily task types the tool actually resolves rather than summarizes. For adoption, track time to competence by role and the number of support tickets in the first 30 days. For compliance, confirm that an auditor could reconstruct any AI-assisted action from the log alone. For deployment fit, confirm whether the tool reads and writes through the existing EHR or stands up a parallel data store.

Why Does Baseline Measurement Matter Before a Pilot?

Baseline measurement matters because without it, there is no honest way to know whether the tool changed anything. The demo shows the best case. The deployment reveals the baseline case. The gap between them is where buyer dissatisfaction lives.

A practical sequence is to measure current-state metrics for two weeks, launch the pilot, then re-measure the same metrics at weeks 2, 4, and 8. Week 2 captures early friction. Week 4 captures the point where training should be paying off. Week 8 captures the steady state. A tool that improves at week 2 but regresses by week 8 is failing adoption, not capability. A tool that is rough at week 2 but strong by week 8 is succeeding despite a learning curve.

What does a defensible pilot scorecard look like in practice?

A defensible scorecard pairs each of the 5 categories with a number the team agreed to measure before the demo. The reason to set the metrics first is that many tools look impressive in isolation but fail to move the metrics that actually drive burnout. A scribe might reduce note time by fifteen minutes. If inbox time is ninety minutes, the net impact on the physician's evening is marginal. Vendors who resist this kind of measurement are telling you something. The ones who welcome it are telling you something different.

How Does an Overlay Model Change the Pilot Math?

An overlay model changes the pilot math because it removes the migration cost from the experiment. When a tool runs as a SMART on FHIR overlay on the current EHR, the practice can pilot a single provider or one clinic within weeks, measure against the baseline, and remove the overlay without disruption if it does not meet thresholds. The underlying system of record is unchanged throughout.

That reversibility lowers procurement risk. A full EHR switch is a 12 to 18 month commitment that is painful to reverse. An overlay pilot is a four to six week commitment that costs little to unwind. The evaluation question shifts from “are we confident enough to commit” to “does the data support expanding.”


Frequently Asked Questions

What metrics are used to measure success during a clinical AI pilot?

The most decision-relevant metrics are after-hours EHR minutes per clinician per day, inbox processing time, follow-up completion rate, time to competence per role, and whether AI-assisted actions are fully auditable. Note quality alone is not sufficient because it does not predict whether after-hours burden falls.

Why do clinical AI demos look better than real deployments?

Because demos use clean encounters and clean data, while real outpatient work involves fragmented histories, message backlogs, prior authorizations, and specialty data. The gap between a controlled demo and a messy deployment is where most buyer dissatisfaction originates.

How long should a clinical AI pilot run?

Long enough to pass the learning curve and reach steady state. A common structure is a two-week baseline measurement followed by outcome checks at weeks 2, 4, and 8. That window distinguishes early friction from genuine capability problems.

Can a clinic pilot clinical AI without replacing its EHR?

Yes. A SMART on FHIR overlay deploys on top of the existing EHR through standard interfaces. The overlay adds the workflow capabilities while the current system remains the source of truth, which makes a pilot reversible and lower risk.

Is Thyra just an AI scribe or a full workflow system?

Thyra is a full workflow system, not just an AI scribe. It connects Smart Inbox triage, Smart Search, longitudinal patient context, and follow-up execution, and it welcomes outcome measurement against a pre-pilot baseline.

About the Author

Jean Jacques Nya Ngatchou, MD is a board-certified endocrinologist and the founder of Thyra, an AI-powered EHR for specialty and primary care workflows. He previously practiced at Optum and completed his endocrinology fellowship at the University of Washington. Thyra is backed by INSEAD AI Venture Lab and Google Cloud for Startups.

Sources